Bamias, Aristotelis
Karavasilis, Vasilios
Gavalas, Nikolaos
Tzannis, Kimon
Samantas, Epaminontas
Aravantinos, Gerasimos
Koutras, Angelos
Gkerzelis, Ioannis
Kostouros, Euthymios
Koutsoukos, Konstantinos
Zagouri, Flora
Fountzilas, George
Dimopoulos, Meletios-Athanasios
Funding for this research was provided by:
Hellenic Genito-Urinary Cancer Group
F. Hoffmann-La Roche
Pfizer
Article History
Received: 12 June 2018
Accepted: 16 October 2018
First Online: 29 October 2018
Compliance with ethical standards
:
: Aristotelis Bamias: Honoraria, Advisory Boards, Research funding: Novartis, Pfizer, Roche, Astra-Zeneca, BMS, Bayer. <i>Vasilios Karavasilis</i> Advisory Board: Amgen, Pfizer, Novartis, BI, Lilly, Roche, Astellas, Genesis-Pharma and Janssen. <i>Gerasimos Aravantinos</i> Advisory Board: Novartis, BMS, Roche Hellas, Astra Zeneca, Sanofi, Amgen, Genesis Pharma, Merck, Pfizer. Angelos Koutras: Advisory Board: Roche. George Fountzilas. Advisory Board: Pfizer, Sanofi and Roche. Honoraria from Astra-Zeneca. Meletios-Athanassios Dimopoulos: Honoraria, Advisory Board: Janssen, Celgene, Amgen and Takeda.